002070 — Vivien Balance Sheet
0.000.00%
- KR₩25bn
- KR₩95bn
- KR₩217bn
Annual balance sheet for Vivien, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9,209 | 34,506 | 16,836 | 17,604 | 11,981 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19,106 | 25,939 | 27,298 | 26,083 | 23,541 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 70,253 | 103,358 | 88,584 | 90,886 | 86,470 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 40,566 | 38,341 | 40,530 | 40,439 | 38,810 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 133,299 | 189,039 | 198,167 | 201,061 | 191,083 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 23,448 | 34,218 | 26,917 | 98,655 | 99,057 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 29,965 | 98,783 | 94,893 | 104,755 | 102,975 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 103,334 | 90,256 | 103,274 | 96,306 | 88,108 |
Total Liabilities & Shareholders' Equity | 133,299 | 189,039 | 198,167 | 201,061 | 191,083 |
Total Common Shares Outstanding |